What is it about?
The hypothesis that the incorporation of a carboranyl moiety instead of a phenyl ring into scaffolds of established NSAIDs may lead to compounds with improved activity is being tested.
Featured Image
Read the Original
This page is a summary of: Carboranyl Derivatives of Rofecoxib with Cytostatic Activity against Human Melanoma and Colon Cancer Cells, Scientific Reports, March 2020, Springer Science + Business Media,
DOI: 10.1038/s41598-020-59059-3.
You can read the full text:
Contributors
The following have contributed to this page
